Your browser doesn't support javascript.
loading
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.
Coombes, R C; Badman, P D; Lozano-Kuehne, J P; Liu, X; Macpherson, I R; Zubairi, I; Baird, R D; Rosenfeld, N; Garcia-Corbacho, J; Cresti, N; Plummer, R; Armstrong, A; Allerton, R; Landers, D; Nicholas, H; McLellan, L; Lim, A; Mouliere, F; Pardo, O E; Ferguson, V; Seckl, M J.
Afiliación
  • Coombes RC; Department of Surgery and Cancer, Imperial College London, London, UK. c.coombes@imperial.ac.uk.
  • Badman PD; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Lozano-Kuehne JP; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Liu X; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Macpherson IR; Cancer Research UK Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Zubairi I; Cancer Research UK Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Baird RD; Medical Oncology, Addenbrooke's Hospital, Breast Cancer Research Unit, Cancer Research UK Cambridge Centre, Cambridge, UK.
  • Rosenfeld N; Medical Oncology, Addenbrooke's Hospital, Breast Cancer Research Unit, Cancer Research UK Cambridge Centre, Cambridge, UK.
  • Garcia-Corbacho J; Medical Oncology, Addenbrooke's Hospital, Breast Cancer Research Unit, Cancer Research UK Cambridge Centre, Cambridge, UK.
  • Cresti N; Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK.
  • Plummer R; Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK.
  • Armstrong A; Breast Research Office, The Christie NHS Foundation Trust, Christie Hospital, Manchester, UK.
  • Allerton R; C8 Admin Offices, Russell's Hall Hospital, Russells Hall, UK.
  • Landers D; Astrazeneca, Cheshire, UK.
  • Nicholas H; Department of Surgery and Cancer, Imperial College London, London, UK.
  • McLellan L; ECMC Programme Office, Research and Innovation, Cancer Research UK, London, UK.
  • Lim A; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
  • Mouliere F; Medical Oncology, Addenbrooke's Hospital, Breast Cancer Research Unit, Cancer Research UK Cambridge Centre, Cambridge, UK.
  • Pardo OE; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Pathology, Cancer Centre Amsterdam, Amsterdam, The Netherlands.
  • Ferguson V; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Seckl MJ; Department of Surgery and Cancer, Imperial College London, London, UK.
Nat Commun ; 14(1): 260, 2023 Jan 17.
Article en En | MEDLINE | ID: mdl-36650166
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article